Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adma Biologics (ADMA) Return on Assets: 2011-2025

Historic Return on Assets for Adma Biologics (ADMA) over the last 10 years, with Sep 2025 value amounting to 0.37%.

  • Adma Biologics' Return on Assets rose 19.00% to 0.37% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.37%, marking a year-over-year increase of 19.00%. This contributed to the annual value of 0.48% for FY2024, which is 57.00% up from last year.
  • According to the latest figures from Q3 2025, Adma Biologics' Return on Assets is 0.37%, which was down 4.92% from 0.39% recorded in Q2 2025.
  • Over the past 5 years, Adma Biologics' Return on Assets peaked at 0.45% during Q4 2024, and registered a low of -0.34% during Q1 2021.
  • Its 3-year average for Return on Assets is 0.14%, with a median of 0.10% in 2024.
  • In the last 5 years, Adma Biologics' Return on Assets declined by 7bps in 2021 and then soared by 53bps in 2024.
  • Adma Biologics' Return on Assets (Quarterly) stood at -0.28% in 2021, then climbed by 10bps to -0.18% in 2022, then grew by 10bps to -0.08% in 2023, then surged by 53bps to 0.45% in 2024, then increased by 19bps to 0.37% in 2025.
  • Its Return on Assets stands at 0.37% for Q3 2025, versus 0.39% for Q2 2025 and 0.41% for Q1 2025.